Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
11,331,532
-
Shares change
-
+10,554,876
-
Total reported value, excl. options
-
$175,598,863
-
Value change
-
+$163,278,863
-
Number of buys
-
22
-
Price
-
$15.87
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2019
24 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q4 2019.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,331,532 shares
of 202,731,676 outstanding shares and own 5.6% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4,426,106 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,020,000 shares), BVF INC/IL (999,996 shares), Ghost Tree Capital, LLC (800,000 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (621,505 shares), BlackRock Inc. (599,867 shares), Ikarian Capital, LLC (504,117 shares), Athanor Capital, LP (500,000 shares), Polar Capital LLP (393,750 shares), and Sio Capital Management, LLC (307,700 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.